• About Us
    • Introduction to Hayat
    • Mission and Vision
    • Pillars of Success
    • Chairman’s Word
    • Our Founder
    • Hayat Brochure (PDF)
  • Competencies
    • Quality and Compliance
    • Regulatory Competency
    • Market & Product Strategy
    • MENA Market Access
  • Products
    • Allergies
    • Cardiovascular System
    • Dermatology
    • Gastrointestinal System
    • Infectious Disease
    • Inner Ear & Balance
    • Men’s Health
    • Neurology
    • Pain & Inflammation
    • Respiratory System
    • Vitamins & Supplements
    • Women’s Health
  • Careers
  • Partners
  • Contact Us
Search
Hayat Pharmaceutical Industries Co. – Amman Jordan
  • About Us
    • Introduction to Hayat
    • Mission and Vision
    • Pillars of Success
    • Chairman’s Word
    • Our Founder
    • Hayat Brochure (PDF)
  • Competencies
    • Quality and Compliance
    • Regulatory Competency
    • Market & Product Strategy
    • MENA Market Access
  • Products
    • Allergies
    • Cardiovascular System
    • Dermatology
    • Gastrointestinal System
    • Infectious Disease
    • Inner Ear & Balance
    • Men’s Health
    • Neurology
    • Pain & Inflammation
    • Respiratory System
    • Vitamins & Supplements
    • Women’s Health
  • Careers
  • Partners
  • Contact Us
Home Announcements

Hayat-sponsored study tests efficacy of Serratiopeptidase in pain and inflammation modulation

June 12, 2018

More details on this study will be provided soon.

Previous articleBiodal® Drops for children launched (vitamin D 400 I.U/ml)
Next articleDr. Michael Holick, author of “The Vitamin D Solution”, gives a seminar in Amman, Jordan

Our Main Products

Biodal® (vitamin D)

Deflat® (simethicone)

Serodase® (serratiopeptidase)

Navigation Menu

  • Home
  • About Us
  • Products
  • Careers
  • Partnerships
  • Contact
© Hayat Pharmaceutical Industries Co. PLC. - Amman, Jordan. Site design by Samer Kurdi
Edit with Live CSS
Save
Write CSS OR LESS and hit save. CTRL + SPACE for auto-complete.